X0306
4
2015-06-01
0
0000885590
Valeant Pharmaceuticals International, Inc.
VRX
0001577638
Mirovsky Pavel
2150 ST. ELZEAR BLVD. WEST
LAVAL
A8
H7L 4A8
QUEBEC, CANADA
0
1
0
0
EVP, Pres. & GM Valeant EMENA
Common Stock, no par value
2015-06-01
4
M
0
100
51.01
A
36775
D
Common Stock, no par value
2015-06-01
4
S
0
100
240
D
36675
D
Common Stock, no par value
2015-06-02
4
M
0
14900
51.01
A
51575
D
Common Stock, no par value
2015-06-02
4
S
0
14900
237.94
D
36675
D
Common Stock, no par value
2015-06-02
4
S
0
23000
238.044
D
13675
D
Non-Qualified Stock Options (right to purchase)
51.01
2015-06-01
4
M
0
100
0
D
2016-05-15
2022-05-15
Common shares, no par value
100
19900
D
Non-Qualified Stock Options (right to purchase)
51.01
2015-06-02
4
M
0
14900
0
D
2016-05-15
2022-05-15
Common shares, no par value
14900
5000
D
This number represents the weighted average sale price for all sales of common stock acquired upon exercise of options and sold. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.
This number represents the weighted average sale price for all sales of common stock previously held that were sold. Upon request by the Securities and Exchange Commission, the issuer, or any security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each price.
The options vested one-fourth per year over four years starting with the first vest date falling on the first anniversary of the equity grant date, the second vest date falling on the second anniversary of the equity grant date, the third vest date falling on the third anniversary of the equity grant date, and the fourth vest date falling on the fourth anniversary of the equity grant date.
by: Nicholas Zanoni for Pavel Mirovsky
2015-06-03